224.01 USD
↗ 1.12 (0.50%)LIVE (AS OF 12:36 PM EDT)
Open?$222.45
High?$224.86
Low?$222.45
Prev. Close?$222.89
Volume?1.7M
Avg. Volume?7.7M
VWAP?$223.88
Rel. Volume?0.22x
Bid / Ask
Bid?$224.08 × 200
Ask?$224.11 × 100
Spread?$0.03
Midpoint?$224.10
Valuation & Ratios
Market Cap?536.5B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?25.50
P/B Ratio?6.61
EPS?$8.74
Dividend?2.33%
Ex-Dividend?N/A
Johnson & Johnson (JNJ) trades at $224.01 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (25.9%) and a bullish Golden Cross on the moving averages. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 2, 2026.
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
538.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?97
Momentum?31
Short Sent.?57
Piotroski F-Score?3/9Weak
Altman Z-Score?4.77Safe
Confidence?61%Moderate
Short InterestModerate
Short % of Float?0.96%Low
Short Interest?23.0M
Days to Cover?3.1
Free Float2.4B
Avg Daily Volume7.5M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.03Adequate
Quick Ratio?0.77Weak
Cash Ratio?0.38Low
Debt/Equity?0.68Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score67/100
P/E?25.5FAIR▾
Peers56
S&P46
P/B?6.61FAIR▾
Peers33
S&P28
P/S?5.57FAIR▾
Peers45
S&P25
P/FCF?30.8FAIR▾
Peers50
S&P28
EV/EBITDA?17.1FAIR▾
Peers60
S&P38
EV/Sales?5.91FAIR▾
Peers45
S&P29
Returns & Efficiency
ROE?25.9%STRONG▾
Peers67
S&P75
ROA?10.5%STRONG▾
Peers78
S&P76
Cash Flow & Enterprise
FCF?$17.4B
Enterprise Value?$569.8B
Fundamentals ratios updated end of day